Review



cd34 cell fractions  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Miltenyi Biotec cd34 cell fractions
    Cd34 Cell Fractions, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+cell+fraction/CD34-VioBlue/us12203096-489-17-31
    Average 99 stars, based on 4 article reviews
    cd34 cell fractions - by Bioz Stars, 2026-09
    99/100 stars

    Images

    Related Articles

    Isolation:

    Article Title: MECOM promotes leukemia progression and inhibits mast cell differentiation through functional competition with GATA2
    Article Snippet: Mononuclear cells (MNCs) were isolated using Lymphoprep (Alere Technologies AS, Oslo, Norway). .. The CD34 + cell fraction was then isolated from the MNCs using the MidiMACS system (CD34+ Microbead Kit; Miltenyi Biotec; Bergisch Gladbach, Germany) according to the manufacturer’s protocols. .. CB CD34 + cells were incubated in StemSpanTM SFEMII (STEMCELL Technologies) supplemented with 10 ng/ml mouse Flt-3, 10 ng/ml human thrombopoietin (TPO), 10 ng/ml human stem cell factor (SCF), 10 ng/ml human interleukin-3 (IL-3) and 10 ng/ml human interleukin-6 (IL-6) (R&D Systems).

    Article Title: DNA damage response after treatment of cycling and quiescent cord blood hematopoietic stem cells with distinct genotoxic noxae.
    Article Snippet: Density gradient centrifugation was performed using 1.077 g/cm3 Histopaque-1077 Hybri-Max (SigmaAldrich). .. Cells were washed with PBS/EDTA (Miltenyi) and CD34+cell fraction was isolated via magnetic-activated cell sorting using human CD34 MicroBead Kit (Miltenyi). ..

    Article Title: HDAC7 is a potential therapeutic target in acute erythroid leukemia.
    Article Snippet: Mono nuclear cells (MNCs) were isolated from CB by density gradient centrifugation using LymphoprepTM (density 1.077; Alere Technologies AS, Oslo, Norway). .. The CD34+ cell fraction was then isolated from the MNCs using the MidiMACS system (CD34+ Microbead Kit; Miltenyi Biotec; Bergisch Gladbach, Germany) according to the manufacturer’s protocols. .. CB CD34+ cells were incubated in StemSpanTM SFEMII (STEMCELL Technologies) supplemented with 100 ng/ml rhSCF (#255-SC, R&D Systems), 10 ng/ml rhIL-6 (#206-IL, R&D Systems), 1 ng/ml rhIL-3 (#203-IL, R&D Systems) and 1% penicillin–streptomycin (PS, #09367-34, Nacalai).

    Article Title: DNA Damage Response After Treatment of Cycling and Quiescent Cord Blood Hematopoietic Stem Cells With Distinct Genotoxic Noxae
    Article Snippet: Density gradient centrifugation was performed using 1.077 g/cm 3 Histopaque-1077 Hybri-Max (Sigma-Aldrich). .. Cells were washed with PBS/EDTA (Miltenyi) and CD34 + cell fraction was isolated via magnetic-activated cell sorting using human CD34 MicroBead Kit (Miltenyi). ..

    Article Title: HDAC7 is a potential therapeutic target in acute erythroid leukemia
    Article Snippet: Mono nuclear cells (MNCs) were isolated from CB by density gradient centrifugation using LymphoprepTM (density 1.077; Alere Technologies AS, Oslo, Norway). .. The CD34 + cell fraction was then isolated from the MNCs using the MidiMACS system (CD34 + Microbead Kit; Miltenyi Biotec; Bergisch Gladbach, Germany) according to the manufacturer’s protocols. .. CB CD34 + cells were incubated in StemSpanTM SFEMII (STEMCELL Technologies) supplemented with 100 ng/ml rhSCF (#255-SC, R&D Systems), 10 ng/ml rhIL-6 (#206-IL, R&D Systems), 1 ng/ml rhIL-3 (#203-IL, R&D Systems) and 1% penicillin–streptomycin (PS, #09367-34, Nacalai).

    Article Title: MECOM promotes leukemia progression and inhibits mast cell differentiation through functional competition with GATA2
    Article Snippet: Mononuclear cells (MNCs) were isolated using Lymphoprep (Alere Technologies AS, Oslo, Norway). .. The CD34+ cell fraction was then isolated from the MNCs using the MidiMACS system (CD34 + Microbead Kit; Miltenyi Biotec; Bergisch Gladbach, Germany) according to the manufacturer’s protocols. .. CB CD34+ cells were incubated in StemSpanTM SFEMII (STEMCELL Technologies) supplemented with 10 ng/ml mouse Flt-3, 10 ng/ml human thrombopoietin (TPO), 10 ng/ml human stem cell factor (SCF), 10 ng/ml human interleukin-3 (IL-3) and 10 ng/ml human interleukin-6 (IL-6) (R&D Systems).

    FACS:

    Article Title: DNA damage response after treatment of cycling and quiescent cord blood hematopoietic stem cells with distinct genotoxic noxae.
    Article Snippet: Density gradient centrifugation was performed using 1.077 g/cm3 Histopaque-1077 Hybri-Max (SigmaAldrich). .. Cells were washed with PBS/EDTA (Miltenyi) and CD34+cell fraction was isolated via magnetic-activated cell sorting using human CD34 MicroBead Kit (Miltenyi). ..

    Article Title: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy
    Article Snippet: For cell sorting, MNCs were enriched in CD34 + cells using magnetic sorting with the CD34 Microbead Kit (Miltenyi Biotec) and further purified by FACS. .. CD3 + T cells were positively selected from the CD34 − cell fraction using the human CD3 MicroBead Kit (Miltenyi Biotec) and further purified by FACS. .. Neutrophils were purified by FACS of CD66b + cells (G10F5; 1:20 dilution; BD Biosciences) from BM or PB cells magnetically enriched in CD15 + cells using the human CD15 MicroBead Kit (Miltenyi Biotec).

    Article Title: DNA Damage Response After Treatment of Cycling and Quiescent Cord Blood Hematopoietic Stem Cells With Distinct Genotoxic Noxae
    Article Snippet: Density gradient centrifugation was performed using 1.077 g/cm 3 Histopaque-1077 Hybri-Max (Sigma-Aldrich). .. Cells were washed with PBS/EDTA (Miltenyi) and CD34 + cell fraction was isolated via magnetic-activated cell sorting using human CD34 MicroBead Kit (Miltenyi). ..

    Article Title: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy.
    Article Snippet: For cell sorting, MNCs were enriched in CD34+ cells using magnetic sorting with the CD34 Microbead Kit (Miltenyi Biotec) and further purified by FACS. .. CD3+ T cells were positively selected from the CD34− cell fraction using the human CD3 MicroBead Kit (Miltenyi Biotec) and further purified by FACS. .. Neutrophils were purified by FACS of CD66b+ cells (G10F5; 1:20 dilution; BD Biosciences) from BM or PB cells magnetically enriched in CD15+ cells using the human CD15 MicroBead Kit (Miltenyi Biotec).

    Purification:

    Article Title: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy
    Article Snippet: For cell sorting, MNCs were enriched in CD34 + cells using magnetic sorting with the CD34 Microbead Kit (Miltenyi Biotec) and further purified by FACS. .. CD3 + T cells were positively selected from the CD34 − cell fraction using the human CD3 MicroBead Kit (Miltenyi Biotec) and further purified by FACS. .. Neutrophils were purified by FACS of CD66b + cells (G10F5; 1:20 dilution; BD Biosciences) from BM or PB cells magnetically enriched in CD15 + cells using the human CD15 MicroBead Kit (Miltenyi Biotec).

    Article Title: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy.
    Article Snippet: For cell sorting, MNCs were enriched in CD34+ cells using magnetic sorting with the CD34 Microbead Kit (Miltenyi Biotec) and further purified by FACS. .. CD3+ T cells were positively selected from the CD34− cell fraction using the human CD3 MicroBead Kit (Miltenyi Biotec) and further purified by FACS. .. Neutrophils were purified by FACS of CD66b+ cells (G10F5; 1:20 dilution; BD Biosciences) from BM or PB cells magnetically enriched in CD15+ cells using the human CD15 MicroBead Kit (Miltenyi Biotec).



    Similar Products

    99
    Miltenyi Biotec cd34 cell fractions
    Cd34 Cell Fractions, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+cell+fraction/CD34-VioBlue/us12203096-489-17-31
    Average 99 stars, based on 1 article reviews
    cd34 cell fractions - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    Miltenyi Biotec cd34 cell fraction
    Cd34 Cell Fraction, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+cell+fraction/CD34-VioBlue/pm39277669-53-1-17
    Average 99 stars, based on 1 article reviews
    cd34 cell fraction - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    Qiagen cd34 cell fraction
    Cd34 Cell Fraction, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+cell+fraction/miRNeasy+Micro+Kit/pmc11604037-358-7-18
    Average 99 stars, based on 1 article reviews
    cd34 cell fraction - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    90
    Glaxo Smith autologous cd34+-enriched cell fraction strimvelis
    FDA/EMA approved gene therapy product for rare monogenic diseases
    Autologous Cd34+ Enriched Cell Fraction Strimvelis, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+cell+fraction/strimvelis/pmc11222908-222-7-8
    Average 90 stars, based on 1 article reviews
    autologous cd34+-enriched cell fraction strimvelis - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    FDA/EMA approved gene therapy product for rare monogenic diseases

    Journal: Clinical and Experimental Pediatrics

    Article Title: Development of orphan drugs for rare diseases

    doi: 10.3345/cep.2023.00535

    Figure Lengend Snippet: FDA/EMA approved gene therapy product for rare monogenic diseases

    Article Snippet: For instance, an autologous CD34+-enriched cell fraction, Strimvelis (GlaxoSmithKline plk, London, UK), which contains CD34+ cells transduced with a retroviral vector that encodes the human ADA cDNA sequence for ADA deficiency (introduced in 2016), and voretigene neparvovec-rzyl (Luxturna, Spark Therapeutics, Philadelphia, USA), for retinal dystrophy caused by mutations in the RPE65 gene, were approved by the FDA in 2017 at a cost of $850,000 per eye [ ].

    Techniques: Plasmid Preparation, In Vivo, Ex Vivo, Mutagenesis, Modification, Variant Assay